Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Quality of life in men undergoing active surveillance for localized prostate cancer.

Bergman J, Litwin MS.

J Natl Cancer Inst Monogr. 2012 Dec;2012(45):242-9. doi: 10.1093/jncimonographs/lgs026.

PMID:
23271780
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Risk stratification of men choosing surveillance for low risk prostate cancer.

Tseng KS, Landis P, Epstein JI, Trock BJ, Carter HB.

J Urol. 2010 May;183(5):1779-85. doi: 10.1016/j.juro.2010.01.001. Epub 2010 Mar 20.

PMID:
20304433
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Prospective study of determinants and outcomes of deferred treatment or watchful waiting among men with prostate cancer in a nationwide cohort.

Shappley WV 3rd, Kenfield SA, Kasperzyk JL, Qiu W, Stampfer MJ, Sanda MG, Chan JM.

J Clin Oncol. 2009 Oct 20;27(30):4980-5. doi: 10.1200/JCO.2008.21.2613. Epub 2009 Aug 31.

PMID:
19720918
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Low risk prostate cancer in men under age 65: the case for definitive treatment.

Jang TL, Yossepowitch O, Bianco FJ Jr, Scardino PT.

Urol Oncol. 2007 Nov-Dec;25(6):510-4. Review.

PMID:
18047962
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Continuing controversy over monitoring men with localized prostate cancer: a systematic review of programs in the prostate specific antigen era.

Martin RM, Gunnell D, Hamdy F, Neal D, Lane A, Donovan J.

J Urol. 2006 Aug;176(2):439-49. Review.

PMID:
16813862
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk